Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:248-255
Published online before print December 8, 2005, doi: 10.1161/01.STR.0000195177.61184.49
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/1/248    most recent
01.STR.0000195177.61184.49v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leblanc, G. G.
Right arrow Articles by Hachinski, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leblanc, G. G.
Right arrow Articles by Hachinski, V.
Related Collections
Right arrow Behavioral/psychosocial - stroke
Right arrow Animal models of human disease
Right arrow Ischemic biology - basic studies
Right arrow Genetics of Stroke
Right arrow Pathology of Stroke

(Stroke. 2006;37:248.)
© 2006 American Heart Association, Inc.


Comments, Opinions, and Reviews

Genetics of Vascular Cognitive Impairment

The Opportunity and the Challenges

Gabrielle G. Leblanc, PhD; James F. Meschia, MD; Donald T. Stuss, PhD Vladimir Hachinski, MD

From the Neurogenetics Group, National Institute of Neurological Disorders and Stroke (G.G.L.), Bethesda, Md; Department of Neurology (J.F.M.), Mayo Clinic, Jacksonville, Fla; Baycrest Centre for Geriatric Care (D.T.S.), The Rotman Research Institute, University of Toronto, Ontario, Canada; London Health Sciences Center (V.H.), University of Western Ontario, London, Ontario, Canada.

Correspondence to Gabrielle G. Leblanc, PhD, National Institute for Neurological Disorders and Stroke, 6001 Executive Blvd, Room 2114, Bethesda, MD 20892. E-mail leblancg{at}ninds.nih.gov

Background and Purpose— This review considers the current state of knowledge of genetic factors underlying vascular cognitive impairment (VCI).

Summary of Review— We argue here that genes conferring susceptibility to VCI must be of 2 nonmutually exclusive classes: (1) genes that confer susceptibility to cerebrovascular disease, and (2) genes that determine brain tissue responses to cerebrovascular disease (ie, render parenchymal tissue more or less susceptible to injury or able to repair itself after injury). Although some progress has been made in identifying genes of the first class, little has been done to explore genes of the second class. Evidence for the existence of such genes is presented. We discuss the advantages and disadvantages of different forms of cerebrovascular disease for studying these genes, and different study designs that might be used.

Conclusion— The most critical challenge for genetic studies of VCI is to identify quantifiable phenotypes that can be reliably and effectively determined in large samples of subjects.


Key Words: cerebrovascular disorders • cognition • dementia • ischemia




This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
L. H. Kuller
Green Banana*: Dementia Epidemiology Research: It Is Time to Modify the Focus of Research
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1314 - 1318.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. Hachinski, C. Iadecola, R. C. Petersen, M. M. Breteler, D. L. Nyenhuis, S. E. Black, W. J. Powers, C. DeCarli, J. G. Merino, R. N. Kalaria, et al.
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
Stroke, September 1, 2006; 37(9): 2220 - 2241.
[Abstract] [Full Text] [PDF]